DexCom
DXCM
YETI Holdings
YETI
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Lantheus
LNTH
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -34.66%881.69K | -26.96%981.27K | -20.83%975.95K | 41.91%4.95M | 170.82%1.03M | 4.38%1.35M | -23.28%1.34M | -34.99%1.23M | 32.41%3.49M | -1.45M |
Operating revenue | -34.66%881.69K | -26.96%981.27K | -20.83%975.95K | 41.91%4.95M | 170.82%1.03M | 4.38%1.35M | -23.28%1.34M | -34.99%1.23M | 32.41%3.49M | ---1.45M |
Cost of revenue | -26.04%709.05K | -25.58%701.14K | -18.27%688.73K | 57.33%3.42M | 136.35%676.51K | -13.22%958.67K | -43.28%942.2K | -33.59%842.68K | -25.94%2.17M | -1.86M |
Gross profit | -55.81%172.65K | -30.20%280.13K | -26.37%287.21K | 16.45%1.53M | -14.63%350.6K | 107.82%390.67K | 345.84%401.32K | -37.83%390.08K | 539.64%1.32M | 410.69K |
Operating expense | -45.96%970.08K | -30.52%1.48M | -3.58%1.97M | -26.78%7.96M | -10.16%1.98M | -14.73%1.8M | -42.71%2.14M | -27.72%2.05M | -67.25%10.87M | 2.21M |
Selling and administrative expenses | -45.96%970.08K | -30.52%1.48M | -3.58%1.97M | -26.78%7.96M | -10.16%1.98M | -14.73%1.8M | -42.71%2.14M | -27.72%2.05M | 9.89%10.87M | --2.21M |
Operating profit | 43.22%-797.44K | 30.60%-1.2M | -1.79%-1.68M | 32.73%-6.43M | 9.14%-1.63M | 26.75%-1.4M | 52.31%-1.74M | 24.85%-1.66M | 71.47%-9.56M | -1.8M |
Net non-operating interest income expense | 105.42%16.18K | 106.46%15.61K | -41.29%-308.1K | -1,347.74%-1.1M | -1,648.34%-338.69K | -1,071.88%-298.54K | -957.37%-241.57K | -2,602.07%-218.06K | -360.76%-75.76K | -19.37K |
Non-operating interest income | -20.85%16.18K | 193.44%15.93K | 176.91%16.1K | 60.15%53.49K | 632.40%21.81K | 195.29%20.44K | -51.47%5.43K | -52.79%5.81K | 14.96%33.4K | --2.98K |
Non-operating interest expense | --0 | -99.87%324 | 44.81%324.19K | 953.76%1.15M | 1,512.97%360.5K | 884.59%318.98K | 625.73%247K | 998.26%223.87K | --109.17K | --22.35K |
Other net income (expense) | 174.59%315.38K | 193.18%237.82K | 17.17%-3.71M | -1,182.13%-2.71M | -324.21K | -422.81K | 94.60%-255.23K | -4.48M | 250K | |
Gain on sale of security | ---- | 104.26%18K | ---- | ---- | ---- | ---324.21K | ---422.81K | ---- | ---- | ---- |
Special income (charges) | ---- | ---- | ---- | 47.85%-2.46M | ---- | ---- | ---- | ---- | ---4.73M | --0 |
-Less:Impairment of capital assets | ---- | ---- | ---- | -47.85%2.46M | ---- | ---- | ---- | ---- | --4.73M | --0 |
Other non- operating income (expenses) | ---- | --297.39K | 193.18%237.82K | -597.14%-1.24M | ---- | ---- | ---- | ---255.23K | --250K | ---- |
Income before tax | 61.46%-781.26K | 63.60%-873.56K | 17.54%-1.76M | 20.38%-11.23M | -198.52%-4.68M | -4.35%-2.03M | 34.47%-2.4M | 69.31%-2.13M | 57.84%-14.11M | -1.57M |
Income tax | 2,044.90%6.74K | 610.00%43.1K | -80.19%5.67K | 221.25%15.71K | -38.44%-19.32K | 4.67%314 | 767.29%6.07K | 28.64K | -410.60%-12.96K | -13.96K |
Net income | 68.94%-885.13K | 86.55%-462.96K | 537.37%12.35M | 6.50%-14.24M | -285.53%-5.13M | -39.16%-2.85M | 28.47%-3.44M | 59.92%-2.82M | 72.62%-15.23M | -1.33M |
Net income continuous Operations | 61.13%-787.99K | 61.90%-916.66K | 18.37%-1.76M | 20.20%-11.25M | -199.96%-4.66M | -4.35%-2.03M | 34.32%-2.41M | 68.90%-2.16M | 57.89%-14.1M | ---1.55M |
Net income discontinuous operations | 88.18%-97.14K | 143.83%453.71K | 2,217.00%14.11M | -163.21%-2.99M | -311.56%-470.83K | -685.70%-822.1K | 9.81%-1.04M | -517.19%-666.56K | 94.87%-1.14M | --222.55K |
Minority interest income | ||||||||||
Net income attributable to the parent company | 68.94%-885.13K | 86.55%-462.96K | 537.37%12.35M | 6.50%-14.24M | -285.53%-5.13M | -39.16%-2.85M | 28.47%-3.44M | 59.92%-2.82M | 72.62%-15.23M | -1.33M |
Preferred stock dividends | 213 | |||||||||
Other preferred stock dividends | 0 | 0 | ||||||||
Net income attributable to common stockholders | 68.94%-885.13K | 86.55%-462.96K | 537.37%12.35M | 6.50%-14.24M | -281.73%-5.08M | -39.18%-2.85M | 28.47%-3.44M | 59.92%-2.82M | 73.00%-15.23M | -1.33M |
Basic earnings per share | 75.00%-0.25 | 88.71%-0.14 | 492.08%3.96 | 15.66%-5.17 | -658.33%-1.82 | -16.28%-1 | 39.22%-1.24 | 66.22%-1.01 | 84.44%-6.13 | -0.24 |
Diluted earnings per share | 75.00%-0.25 | 88.71%-0.14 | 432.67%3.36 | 15.66%-5.17 | -658.33%-1.82 | -16.28%-1 | 39.22%-1.24 | 66.22%-1.01 | 84.44%-6.13 | -0.24 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |